Dr. Reddy's Laboratories Statistics
Total Valuation
Dr. Reddy's Laboratories has a market cap or net worth of INR 1.11 trillion. The enterprise value is 1.04 trillion.
Market Cap | 1.11T |
Enterprise Value | 1.04T |
Important Dates
The next estimated earnings date is Monday, October 28, 2024.
Earnings Date | Oct 28, 2024 |
Ex-Dividend Date | Jul 16, 2024 |
Share Statistics
Dr. Reddy's Laboratories has 166.59 million shares outstanding. The number of shares has increased by 0.20% in one year.
Shares Outstanding | 166.59M |
Shares Change (YoY) | +0.20% |
Shares Change (QoQ) | -0.02% |
Owned by Insiders (%) | 26.81% |
Owned by Institutions (%) | 51.67% |
Float | 119.88M |
Valuation Ratios
The trailing PE ratio is 19.96 and the forward PE ratio is 18.99. Dr. Reddy's Laboratories's PEG ratio is 1.47.
PE Ratio | 19.96 |
Forward PE | 18.99 |
PS Ratio | 3.84 |
PB Ratio | 3.76 |
P/FCF Ratio | 44.67 |
PEG Ratio | 1.47 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.92, with an EV/FCF ratio of 42.09.
EV / Earnings | 18.79 |
EV / Sales | 3.62 |
EV / EBITDA | 12.92 |
EV / EBIT | 15.88 |
EV / FCF | 42.09 |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 10.41.
Current Ratio | 2.55 |
Quick Ratio | 1.66 |
Debt / Equity | 10.41 |
Debt / EBITDA | 0.38 |
Debt / FCF | 1.24 |
Interest Coverage | 33.85 |
Financial Efficiency
Return on equity (ROE) is 20.59% and return on invested capital (ROIC) is 14.06%.
Return on Equity (ROE) | 20.59% |
Return on Assets (ROA) | 10.93% |
Return on Capital (ROIC) | 14.06% |
Revenue Per Employee | 10.67M |
Profits Per Employee | 2.05M |
Employee Count | 27,048 |
Asset Turnover | 0.77 |
Inventory Turnover | 1.95 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.43% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +18.43% |
50-Day Moving Average | 6,789.66 |
200-Day Moving Average | 6,195.34 |
Relative Strength Index (RSI) | 37.14 |
Average Volume (20 Days) | 7,758 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Reddy's Laboratories had revenue of INR 288.51 billion and earned 55.58 billion in profits. Earnings per share was 333.26.
Revenue | 288.51B |
Gross Profit | 170.40B |
Operating Income | 65.60B |
Pretax Income | 72.23B |
Net Income | 55.58B |
EBITDA | 79.54B |
EBIT | 65.60B |
Earnings Per Share (EPS) | 333.26 |
Balance Sheet
The company has 94.63 billion in cash and 30.68 billion in debt, giving a net cash position of 63.95 billion or 383.89 per share.
Cash & Cash Equivalents | 94.63B |
Total Debt | 30.68B |
Net Cash | 63.95B |
Net Cash Per Share | 383.89 |
Equity (Book Value) | 294.63B |
Book Value Per Share | 1,769.05 |
Working Capital | 163.52B |
Cash Flow
In the last 12 months, operating cash flow was 42.68 billion and capital expenditures -17.87 billion, giving a free cash flow of 24.81 billion.
Operating Cash Flow | 42.68B |
Capital Expenditures | -17.87B |
Free Cash Flow | 24.81B |
FCF Per Share | 148.90 |
Margins
Gross margin is 59.06%, with operating and profit margins of 22.74% and 19.26%.
Gross Margin | 59.06% |
Operating Margin | 22.74% |
Pretax Margin | 25.04% |
Profit Margin | 19.26% |
EBITDA Margin | 27.57% |
EBIT Margin | 22.74% |
FCF Margin | 8.60% |
Dividends & Yields
This stock pays an annual dividend of 40.00, which amounts to a dividend yield of 0.60%.
Dividend Per Share | 40.00 |
Dividend Yield | 0.60% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | 11.96% |
Buyback Yield | -0.20% |
Shareholder Yield | 0.40% |
Earnings Yield | 5.01% |
FCF Yield | 2.24% |
Stock Splits
The last stock split was on August 28, 2006. It was a forward split with a ratio of 2.
Last Split Date | Aug 28, 2006 |
Split Type | Forward |
Split Ratio | 2 |